Acumen Pharmaceuticals, Inc. Conversion of Stock, Shares Converted
Acumen Pharmaceuticals, Inc. (ABOS) had Conversion of Stock, Shares Converted of 477.30 thousand shares as of 2021-07-06, per its 10-Q filed 2022-08-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2022-08-15
- 2021-07-06: Conversion of Stock, Shares Converted 477.30K shares.
- 2021-06-30: Conversion of Stock, Shares Converted 6 month 32.15M shares.
- 2020-06-30: Conversion of Stock, Shares Converted 6 month 9.85M shares.
| Period end | Conversion of Stock, Shares Converted | Conversion of Stock, Shares Converted 6 month |
|---|---|---|
| 2021-07-06 | 477.30K shares 10-Q · filed 2022-08-15 | |
| 2021-06-30 | 32.15M shares 10-Q · filed 2021-08-16 | |
| 2020-06-30 | 9.85M shares 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |